Suchergebnisse - "Eickhardt-Dalbøge, Christina Schjellerup"

PubPharm (7)

1

JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms

enthalten in: European journal of haematology | 2024

von Eickhardt-Dalbøge, C. | Nielsen, H. | Fuursted, K. | +15

2

Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study

enthalten in: Blood cancer journal | 2024

von Larsen, M. | Skov, V. | Kjær, L. | +15

3

JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms

enthalten in: European Journal of Haematology | 2024

von Eickhardt‐Dalbøge, C. | Nielsen, H. | Fuursted, K. | +15

4

Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia

enthalten in: Microbiology spectrum | 2023

von Eickhardt-Dalbøge, C. | Ingham, A. | Nielsen, H. | +13

5

The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment

enthalten in: Blood advances | 2023

von Eickhardt-Dalbøge, C. | Ingham, A. | Andersen, L. | +13

6

Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up

enthalten in: European journal of haematology | 2022

von Larsen, M. | Skov, V. | Kjaer, L. | +17

7

Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up

enthalten in: European Journal of Haematology | 2022

von Larsen, M. | Skov, V. | Kjær, L. | +17

1
[1]